David Reese
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Reese
Earlier roles on record: CTO at Amgen Inc (AMGN) until June 30, 2026. The proxy statement of Amgen Inc reports total compensation of $8,126,822 for David Reese in fiscal 2024, including a base salary of $1,268,615. Disclosed compensation is on record for 3 fiscal years. David Reese has spoken on 1 earnings call across 1 company, most recently for Amgen Inc on February 6, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Amgen Inc (AMGN)
Proxy statement
Start not stated–2026-06-30
-
Start not stated–2026-06-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Amgen Inc (AMGN) | CTO | $1,268,615 | $8,126,822 |
| 2023 | Amgen Inc (AMGN) | CTO | $1,212,823 | $7,902,655 |
| 2022 | Amgen Inc (AMGN) | CTO | $1,158,846 | $7,333,124 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.